2026-09-18
How to keep a medication list across doctors
A practical list for people juggling prescriptions, OTC products, and supplements across clinics — what to write down, where to keep copies, and when to update before a visit or the ER.
Blog
I write these after going through my own diagnosis: how to get your file, how to read what comes back, and how trials and insurance actually work. Each claim links to the public page I used. None of it is a clinical review.
This is not clinical evidence and not medical advice. It does not replace your care team. Discuss anything here with your clinician before you act on it. Product questions are on the FAQ.
2026-09-18
A practical list for people juggling prescriptions, OTC products, and supplements across clinics — what to write down, where to keep copies, and when to update before a visit or the ER.
2026-09-14
The scan lands in your portal before anyone has called. Which sections matter, and what to ask when you sit down with your clinician.
2026-09-13
A denial is a letter, not a verdict. You get an internal appeal and then an independent review, each with deadlines that run both ways.
2026-09-13
You have a legal right to see and copy your file. What that covers, what a provider can charge, and how to fix an error once you have it.
2026-09-13
Every trial on this site links to its registry record. Ten minutes with that page answers most first questions.
2026-09-13
This is the document that actually names the cancer. A few words in it carry most of the weight.
2026-09-13
The numbers often hit the portal before anyone has called. What the ranges and flags mean, and what a single result cannot tell you.
2026-09-13
The phase number tells you what question the study is built to answer, and roughly how many people are in it. It does not tell you how promising the treatment is.
2026-09-13
Consent is a conversation, not a signature. These are the questions that conversation is supposed to answer, and where the answers usually live.
2026-09-13
The first time a new treatment is given to people. The study is built around safety and dose, not around proving the drug works.